Unparalleled Global Pharma Services

NeoGenomics’ Pharma Services offers one of the most comprehensive laboratory services menus available for oncology clinical trials. We provide our clients with an unparalleled level of expertise, flexibility, and scalability. Additionally, we offer alternative business models and solutions that extend beyond the lab aiding in the commercialization process post-approval.

Service Differentiators:

  • Rapid project start up
  • Ability to flex and scale support as clinical trial needs change
  • Custom assay design
  • Large clinically validated menu
  • Dedicated project manager
  • Immediate access to medical staff
  • Multiple modality capabilities

Primary Areas of Focus:

  • Oncology
  • Immuno-Oncology

Additional Areas of Focus:

  • Infectious disease
  • Auto-immune
  • Neuroscience
  • Vaccines
  • Others
Why Choose NeoGenomics

Quality:

Quality Expertise:

We have a dedicated department of quality professionals who manage and administer key elements of our QMS, such as:

  • Licensure & credentialing
  • Disaster recovery
  • Proficiency testing
  • Document control
  • Training & competency
  • Sample chain of custody

Test Performance:

All tests are developed and validated in full compliance with all federal, state and local laws, rules and regulations, including CLIA and CAP standards. Test performance is routinely and closely monitored to ensure the timely delivery of accurate test results to our clients and their patients.   


Staff Competency:

All NeoGenomics clinical laboratory personnel are required to have appropriate credentials and experience to perform the tests provided by NeoGenomics. In addition, all NeoGenomics personnel are required to participate in continual training and competency programs to ensure that each employee remains proficient and qualified to perform all testing with optimal expertise.   


Process Improvement:

NeoGenomics adheres to Lean and Six Sigma processes to ensure its continued excellence in services and reduce obstacles throughout our process. In addition, we regularly survey our clients and suppliers to make sure we maintain high levels of service.


Our Pathology Staff:

Our pathology staff have received in-depth training and are certified by equipment manufacturers to perform our FDA-approved companion diagnostic assays.


Audit Success:

NeoGenomics is a publicly traded company (NASDAQ:NEO) and abides by all regulations that help provide transparency to shareholders and investors. NeoGenomics has successfully completed four FDA audits at our Fort Myers and Aliso Viejo facilities with no FDA form 483’s.


2016 – Aliso Viejo
2016 - Fort Myers
2013 – Aliso Viejo
2011 – Aliso Viejo


Medical Staff:

Our medical and scientific staff of over 80 MD and PhD’s are well published and recognized industry leaders. They maintain membership in notable societies, such as:

  • American Society of Hematology (ASH)
  • College of American Pathologists (CAP)
  • American Society of Clinical Oncology (ASCO)
  • American Association of Cancer Researchers (AACR)
  • American Society of Human Genetics (ASHG)
  • And numerous others

NeoGenomics Operates Laboratories in:

Aliso Viejo, CA
​​​​​​​Carslbad, CA
Fresno, CA
Fort Myers, FL
Houston, TX
Nashville, TN 
Tampa, FL
Rolle, Switzerland
​​​​​​​Singapore, Republic of Singapore


Technology Platforms Center of Excellence

We validate assays on any of these widely used platforms:

    MultiOmyx Logo
    Ventana Logo
    Dako Logo
    Leica Logo
    Life Technologies Logo
    Archer Logo
    illuminacsPro Logo
    SureSelect Logo
    AB Logo
    Agilent Logo
    iontorrent Logo
    Roche Logo
    NanoString